Dia Roy

机构：Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Translational Research in Oncology · ORCID：0000-0002-5036-7009

发表论文 28 篇 · 总被引 274 次 · h-index 9

代表论文

• Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors (2023 · Frontiers in Immunology · 被引 47)
• LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses (2024 · Science Immunology · 被引 43)
• The Adroitness of Andrographolide as a Natural Weapon Against Colorectal Cancer (2021 · Frontiers in Pharmacology · 被引 27)
• Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients (2021 · Cancer Immunology Immunotherapy · 被引 24)
• Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination (2023 · Discover Oncology · 被引 21)
• Tumor-Associated CD19+CD39− B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses (2022 · Cancer Immunology Research · 被引 19)